ID

14490

Beschreibung

A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00639691

Link

https://clinicaltrials.gov/show/NCT00639691

Stichworte

  1. 18.04.16 18.04.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

18. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma NCT00639691

Eligibility Asthma NCT00639691

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00639691
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, ≥ 6years of age;
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
who have a diagnosis of allergic asthma ≥ 1 year duration according to american thoracic society (ats) criteria;
Beschreibung

allergic asthma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0155877
UMLS CUI [1,2]
C0040223
severe persistent allergic asthma who remain symptomatic despite optimal therapy (as per canadian asthma consensus report (1999));
Beschreibung

severe persistent allergic asthma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1960048
UMLS CUI [1,2]
C0155877
subjects having successfully completed one of the following protocols: cige025a011e3, cige025a2425, cige025aia05;
Beschreibung

subjects having successfully completed one of the following protocols: cige025a011e3, cige025a2425, cige025aia05;

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
elevated immunoglobin e levels
Beschreibung

IgE level

Datentyp

boolean

Alias
UMLS CUI [1]
C2229760
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
significant systemic disease
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
pregnancy or lactation
Beschreibung

pregnancy or lactation

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
an active lung disease other than allergic asthma (eg: cystic fibrosis, bronchiestasis);
Beschreibung

lung disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0024115
history of food or drug related severe anaphylactoid or anaphylactic reaction(s);
Beschreibung

anaphylactoid or anaphylactic reaction

Datentyp

boolean

Alias
UMLS CUI [1]
C0340865
UMLS CUI [2]
C0002792
current treatment with warfarin (coumadin®), immunomodulatory therapy (e.g., methotrexate, gold, cyclosporine), or antiplatelet therapy.
Beschreibung

warfarin immunomodulatory therapy or antiplatelet therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0043031
UMLS CUI [2]
C1963758
UMLS CUI [3]
C1096021

Ähnliche Modelle

Eligibility Asthma NCT00639691

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00639691
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
male or female, ≥ 6years of age;
boolean
C0001779 (UMLS CUI [1])
allergic asthma
Item
who have a diagnosis of allergic asthma ≥ 1 year duration according to american thoracic society (ats) criteria;
boolean
C0155877 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
severe persistent allergic asthma
Item
severe persistent allergic asthma who remain symptomatic despite optimal therapy (as per canadian asthma consensus report (1999));
boolean
C1960048 (UMLS CUI [1,1])
C0155877 (UMLS CUI [1,2])
subjects having successfully completed one of the following protocols: cige025a011e3, cige025a2425, cige025aia05;
Item
subjects having successfully completed one of the following protocols: cige025a011e3, cige025a2425, cige025aia05;
boolean
C2348568 (UMLS CUI [1])
IgE level
Item
elevated immunoglobin e levels
boolean
C2229760 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
comorbidity
Item
significant systemic disease
boolean
C0009488 (UMLS CUI [1])
pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
lung disease
Item
an active lung disease other than allergic asthma (eg: cystic fibrosis, bronchiestasis);
boolean
C0024115 (UMLS CUI [1])
anaphylactoid or anaphylactic reaction
Item
history of food or drug related severe anaphylactoid or anaphylactic reaction(s);
boolean
C0340865 (UMLS CUI [1])
C0002792 (UMLS CUI [2])
warfarin immunomodulatory therapy or antiplatelet therapy
Item
current treatment with warfarin (coumadin®), immunomodulatory therapy (e.g., methotrexate, gold, cyclosporine), or antiplatelet therapy.
boolean
C0043031 (UMLS CUI [1])
C1963758 (UMLS CUI [2])
C1096021 (UMLS CUI [3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video